COMPANY
About Us
Executive Team
Board of Directors
Scientific Advisory Board
Business Development
Main Investors
Contact Us
TECHNOLOGIES
OPTIREACH Technology
Antibody Fragment Technology
PIPELINE
Overview
OCS-01 Diabetic Macular Edema
OCS-01 Post Cataract Surgery Inflammation
OCS-02 Uveitis
OCS-02 Dry Eye
OCS-05 Glaucoma
NEWS
Press releases
Articles
CAREERS
COMPANY
About Us
Executive Team
Board of Directors
Scientific Advisory Board
Business Development
Main Investors
Contact Us
TECHNOLOGIES
OPTIREACH Technology
Antibody Fragment Technology
PIPELINE
Overview
OCS-01 Diabetic Macular Edema
OCS-01 Post Cataract Surgery Inflammation
OCS-02 Uveitis
OCS-02 Dry Eye
OCS-05 Glaucoma
NEWS
Press releases
Articles
CAREERS
Corporate Events 2020
Augu
st 1
0, 2020
Oculis to Present
Positive End-of-Phase 2 Meeting Outcomes
at the Upcoming 2020 Summer Private Company Showcase
July 30, 2020
Oculis to Present at the LifeSci Partners Private Company Virtual Summer Symposium
June 23, 2020
Oculis to Present at the Upcoming Virtual European Biotech Investor Day 2020
